CG Oncology (CGON) Other Non-Current Assets (2023 - 2026)

CG Oncology has reported Other Non-Current Assets for 4 years, with the latest figure at $2.7 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets rose 418.6% year-over-year to $2.7 million; the trailing twelve-month figure through Mar 2026 stood at $2.7 million (up 418.6% YoY), and the FY2025 full-year result was $1.7 million, up 1685.11% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $2.7 million, up from $1.7 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $4.7 million in Q4 2023, with the low at $53000.0 in Q1 2024.
• Historically, Other Non-Current Assets has averaged $1.0 million across 4 years, with a median of $315000.0 in 2025.
• Annual changes were most pronounced in 2024 — Other Non-Current Assets plunged 97.99% — and 2025, when it surged 1685.11%.
• CG Oncology's Other Non-Current Assets stood at $4.7 million in 2023, then sank by 97.99% to $94000.0 in 2024, then surged by 1685.11% to $1.7 million in 2025, then soared by 59.48% to $2.7 million in 2026.
• The last three Other Non-Current Assets figures came in at $2.7 million (Q1 2026), $1.7 million (Q4 2025), and $114000.0 (Q3 2025), per Business Quant data.